peruvoside
Sign in to savePeruvoside (or cannogenin thevetoside) is a cardiac glycoside for heart failure.
Research
55 papers- Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers.Life sciences · 2020
- Peruvoside is a novel Src inhibitor that suppresses NSCLC cell growth and motility by downregulating multiple Src-EGFR-related pathways.American journal of cancer research · 2022
- The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses.Acta pharmaceutica Sinica. B · 2023
- Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death.Molecules (Basel, Switzerland) · 2016
- Observations on the effects of peruvoside.The Indian journal of medical research · 1971
via PubMed
Wikidata facts
- Mass
- 548.299
Show 3 more facts
- canonical SMILES
- CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C=O)O)OC)O
- isomeric SMILES
- C[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)C=O)O)OC)O
- chemical formula
- C₃₀H₄₄O₉
Sources (2)
via Wikidata · CC0
~1 min read
Article
1 sectionsContents
- References
Peruvoside (or cannogenin thevetoside) is a cardiac glycoside for heart failure.
It is derived from Cascabela thevetia (Thevetia neriifolia).
Connections
medication
Entity
circulatory system
Entity
digital object identifier
Entity
chemical formula
Entity
heart failure
Entity
molar mass
Entity
Library of Congress Control Number
Entity
Q180686
Entity
Digitalis
Entity
CAS Registry Number
Entity
Kalanchoe
Entity
Q229883
Entity
PubChem
Entity
Anatomical Therapeutic Chemical Classification System
Entity
Bufo
Entity
clinical trial
Entity
World Health Organization Model List of Essential Medicines
Entity
simplified molecular input line entry specification
Entity
Scilla
Entity
digoxin
Entity